Coronavirus vaccine development: who does this and how long to wait 

In February, the World Health Organization (WHO) estimated that it would take 19 months to develop a vaccine against the coronavirus disease COVID-18. Edition Fox News collected information on the progress of several large companies in their search for medicines.

Photo: Shutterstock

Modern Inc.

On January 23, Moderna received funding from the Epidemic Preparedness Coalition (CEPI) for the development of a vaccine against COVID-19.

On February 21, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it would begin registration of 45 adult patients in a phase I clinical trial to test mRNA-1273 as a vaccine for COVID-19. The process should end on June 1, 2021.

On February 24, a biotechnology company announced that it had shipped the first batch of mRNA-1273 to the NIAID for clinical trials in the United States.

Patients will be closely monitored for one year. The test will be carried out at the Washington Research Institute in Seattle (Washington).

Glaxosmithkline

Glaxosmithkline, a leading vaccine manufacturer, is known for marketing vaccines against human papillomavirus (HPV) and seasonal flu.

On February 3, it was announced that the University of Queensland would gain access to Glaxosmithkline technology, which could enhance the response of the vaccine and reduce the amount needed for the result.

On the subject: Be careful: how scammers profit from panic due to coronavirus

On February 24, GSK announced that Clover Biopharmaceuticals, a Chinese biotechnology company, had entered into research cooperation with it, they also have their own version of a vaccine called COVID-19 S-Trimer.

GSK will give Clover access to its system for further study.

Johnson & Johnson

On February 18, 2020, Johnson & Johnson announced that its research arm, Janssen Pharmaceutical, will expand its partnership with the Biomedical Advanced Research and Development Administration (BARDA) to seek treatments for COVID-19.

Johnson & Johnson will also look at the already known pathophysiology of the coronavirus to determine if previously tested drugs can be used to help patients survive.

“Johnson & Johnson has a long history of involvement in the fight against epidemics and will continue to mobilize resources to support global efforts to combat the current coronavirus outbreak,” said Dr. Paul Stoffels, Johnson & Johnson executive vice president and chief scientific officer.

Sanofi pasteur

Sanofi has teamed up with the US Department of Health and Human Services (HHS) to share its technology platform for recombinant technology to accelerate the search for a potential vaccine.

Sanofi will also partner with the Office of Advanced Research and Development in Biomedicine (BARDA).

On the subject: Study: Chinese coronavirus was more active than thought

“Tackling a global health threat like this novel coronavirus will require a collaborative effort, which is why we are working with BARDA,” said David Lowe, global head of vaccines at Sanofi. “While we leverage our expertise where possible, we believe that collaboration with BARDA can provide the most significant results in protecting communities from this threat.”

Inovio pharmaceuticals

Inovio CEO J. Joseph Kim said in an interview that a biotechnology company based outside of Philadelphia hopes that by the end of 2020 at least 1 million doses will be available to the public before developing a large batch of 50 million.

Inovio had previously worked on a vaccine for another coronavirus called the Middle East Respiratory Syndrome, or MERS, and might be able to use its past research to develop the current drug.

Read the latest news and everything you need to know about the outbreak of a new coronavirus from China. ForumDaily special project “Chinese Coronavirus”.

Read also on ForumDaily:

Be careful: how scammers profit from panic due to coronavirus

Study: Chinese coronavirus was more active than thought

Three ways to protect your finances during a market panic due to coronavirus

Virologist gave valuable advice on how to avoid getting COVID-19 during a pandemic

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.